Jakob Dupont

CIK 1553335 · EVP, Head of R&D · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.10M

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$1.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLT Director $4.56 $0 5 2026-06-11
PYXS Director 38,741 $1.76 $68.2K $0 5 2026-03-25
ATRA EVP, Head of R&D 290,794 $10.41 $3.03M -$573.0K 15 2023-03-06
Apexigen, Inc. (APGNW) Delisted Director $0.03 $0 1 2022-10-03
GOSS Chief Medical Officer 46,500 $0.16 $7.5K -$631.5K 3 2020-02-19

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-04-14 Mixed -$32.9K
2015-03-12 Mixed -$33.9K
2015-02-12 Mixed -$29.5K
2015-01-14 Mixed -$32.0K
2015-01-07 Mixed -$138.3K
2014-12-22 Grant (A) $0
2014-07-25 Mixed -$27.7K
2014-03-27 Grant (A) +20,000 $0
2013-07-19 Grant (A) $0
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.